Samsung Electronics Sets Its Sights on Healthcare with Xealth Acquisition
Samsung Electronics Co., a titan of innovation, is taking a bold step into the realm of healthcare. In a strategic move to bolster its non-semiconductor businesses, the South Korean company has announced its acquisition of Xealth, a U.S.-based platform focused on digital health solutions. This acquisition, aimed to be finalized by the end of the year, underlines Samsung’s commitment to diversifying its portfolio and establishing new growth engines—particularly in sectors like robotics, healthcare, consumer audio, and climate control systems.
A Focus on Digital Health Innovation
Founded in 2017 as a spin-off from the Providence health system, Xealth has grown into a pivotal player in the healthcare landscape. It empowers hospitals to manage a spectrum of digital health applications, enabling better patient care through a unified platform. By supporting over 500 U.S. hospitals, including major players like Advocate Health and Banner Health, Xealth facilitates real-time data integration between patients and healthcare providers, enhancing the overall patient experience.
Synergy Between Technologies
Samsung envisions a promising synergy emerging from the acquisition. The integration of Xealth’s digital health infrastructure with Samsung’s AI-powered wearables, such as the Galaxy smartphone, Galaxy Ring, and Galaxy Watch series, aims to create a seamless health management experience. By connecting real-time health data from consumers directly to their clinical providers, Samsung is positioning itself at the forefront of personalized and connected care options.
TM Roh, the president and acting head of Samsung’s Device eXperience Division, emphasized the strategic importance of this acquisition, stating that Xealth’s extensive healthcare expertise will serve as a foundation to enhance support for health systems and digital health partners.
Expanding Beyond Core Businesses
Samsung’s move into healthcare is part of a broader strategy to diversify its business interests and reduce reliance on its traditional semiconductor and smartphone operations. The acquisition of Xealth is not a standalone endeavor; rather, it represents Samsung’s third acquisition in a non-chip sector in 2025 alone. Earlier this year, the company also acquired FläktGroup, a German manufacturer specializing in HVAC systems, for approximately $1.8 billion, as well as Masimo Corp.’s audio business for $350 million through its subsidiary Harman International Industries.
A Community of Growth
In addition to these acquisitions, Samsung has positioned itself as a significant stakeholder in Rainbow Robotics Co., a collaborative robot maker in Korea, and has brought on board Oxford Semantic Technologies, a U.K.-based deep tech startup. During a recent shareholders’ meeting, Samsung executives reiterated their commitment to pursuing meaningful mergers and acquisitions in high-growth sectors, including medical technology and next-generation chips.
Elevating Healthcare through Technology
The Xealth acquisition is expected to significantly enhance Samsung’s presence in the global healthcare market. By leveraging its own Samsung Health platform, which allows users to track health records, manage medications, and monitor dietary habits, Samsung aims to complement and amplify the work being done by Xealth. The collaboration promises to bridge essential gaps in healthcare delivery.
Xealth’s CEO, Mike McSherry, articulated the potential of this partnership by highlighting how customer health data from wearables could provide valuable context that typically isn’t available from clinical records alone. Together, they plan to create a robust connection between home health monitoring systems and clinical decision-making processes.
Looking Ahead
As Samsung continues to shape its future in various industries, the Xealth acquisition marks a significant milestone in its journey to redefine healthcare solutions. The integration of innovative technologies with healthcare infrastructures is poised to deliver unprecedented benefits to patients and providers alike, reflecting Samsung’s steadfast commitment to driving impactful change in how health is managed worldwide.
